The University of Chicago Header Logo

Connection

James Dignam to Quinazolines

Back to Details
This is a "connection" page, showing publications James Dignam has written about Quinazolines.
James Dignam
Connection Strength
0.074
Quinazolines
  1. Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2010 Jul 10; 28(20):3336-43.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.